Fact checked byGina Brockenbrough, MA

Read more

November 10, 2022
1 min read
Save

ASN celebrates 50th anniversary of Medicare End-Stage Renal Disease Program

Fact checked byGina Brockenbrough, MA
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Fifty years after Congress enacted the End-Stage Renal Disease Program in 1972, the American Society of Nephrology celebrates the milestone in American kidney health.

The program provides coverage for patients with kidney failure without notice to a patient’s age or income, according to a press release.

people as kidneys

The program provides coverage for patients with kidney failure without notice to a patient’s age or income. Source: Adobe Stock

“Over the last half century, millions of people have relied on this program to access life-saving care. The advent of new therapies and increased awareness of kidney diseases, underlying causes, and health disparities hold promise to delay and prevent the progression of kidney failure,” Susan E. Quaggin, MD, FASN, president of the ASN, said in the release. “I am thrilled to see how this progress will fuel new enthusiasm and innovation in the field of nephrology and improve the lives of the 37 million affected Americans and loved ones who grapple with these diseases every day.”

The ASN pledged to continue to work with policymakers to create policies that target early diagnosis, transform transplantation, advance innovation and achieve kidney health equity.

“As we look toward the future, we must recommit ourselves to improving care for those impacted by kidney disease and lowering dialysis costs by boosting investment in programs focused on research and innovation, such as KidneyX. We must also prioritize prevention and improve access to transplants,” the Congressional Kidney Caucus said in the release. “We commend leaders across government, the scientific community and patient advocates dedicated to this work.”